Profile
Heikki Joensuu is currently the Vice President-Therapy Area Oncology, R&D at Orion Oyj since 2017.
Prior to this, he worked as the Scientific Director at Boneca Oy.
Heikki Joensuu active positions
| Companies | Position | Start |
|---|---|---|
| ORION OYJ | Corporate Officer/Principal | 2017-11-30 |
Former positions of Heikki Joensuu
| Companies | Position | End |
|---|---|---|
Boneca Oy
 Boneca Oy Medical SpecialtiesHealth Technology The current business of Boneca is to sell BNCT treatments to Finnish and foreign hospitals. The focus of their research work is on clinical trials and their goals are to prove the effectiveness of BNCT treatment and to widen the treatments to tumors located in different areas of the body. They are especially interested in collaborating with companies or research groups manufacturing or developing new compounds targeting specifically to cancer cells and in vivo imaging agents of these compounds. | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ORION OYJ | Health Technology |
| Private companies | 1 |
|---|---|
Boneca Oy
Boneca Oy Medical SpecialtiesHealth Technology The current business of Boneca is to sell BNCT treatments to Finnish and foreign hospitals. The focus of their research work is on clinical trials and their goals are to prove the effectiveness of BNCT treatment and to widen the treatments to tumors located in different areas of the body. They are especially interested in collaborating with companies or research groups manufacturing or developing new compounds targeting specifically to cancer cells and in vivo imaging agents of these compounds. | Health Technology |
- Stock Market
- Insiders
- Heikki Joensuu
